Gilead Sciences Inc (GILD)
89.80
+1.17
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
89.80
0.00 (0.00%)
After-Hours: 16:05
Gilead Sciences Market Cap: 111.91B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 110.46B |
| November 19, 2024 | 109.36B |
| November 18, 2024 | 110.24B |
| November 15, 2024 | 110.17B |
| November 14, 2024 | 114.79B |
| November 13, 2024 | 115.44B |
| November 12, 2024 | 117.59B |
| November 11, 2024 | 120.93B |
| November 08, 2024 | 120.35B |
| November 07, 2024 | 122.01B |
| November 06, 2024 | 114.27B |
| November 05, 2024 | 112.44B |
| November 04, 2024 | 111.96B |
| November 01, 2024 | 111.55B |
| October 31, 2024 | 110.69B |
| October 30, 2024 | 110.01B |
| October 29, 2024 | 109.75B |
| October 28, 2024 | 110.59B |
| October 25, 2024 | 110.89B |
| October 24, 2024 | 110.62B |
| October 23, 2024 | 108.69B |
| October 22, 2024 | 109.85B |
| October 21, 2024 | 107.52B |
| October 18, 2024 | 108.05B |
| October 17, 2024 | 108.85B |
| Date | Value |
|---|---|
| October 16, 2024 | 108.09B |
| October 15, 2024 | 106.93B |
| October 14, 2024 | 105.97B |
| October 11, 2024 | 105.85B |
| October 10, 2024 | 105.50B |
| October 09, 2024 | 107.33B |
| October 08, 2024 | 106.17B |
| October 07, 2024 | 105.20B |
| October 04, 2024 | 105.40B |
| October 03, 2024 | 104.88B |
| October 02, 2024 | 105.59B |
| October 01, 2024 | 104.59B |
| September 30, 2024 | 104.46B |
| September 27, 2024 | 104.09B |
| September 26, 2024 | 103.38B |
| September 25, 2024 | 102.35B |
| September 24, 2024 | 104.32B |
| September 23, 2024 | 104.57B |
| September 20, 2024 | 104.50B |
| September 19, 2024 | 104.45B |
| September 18, 2024 | 104.44B |
| September 17, 2024 | 103.40B |
| September 16, 2024 | 103.53B |
| September 13, 2024 | 103.10B |
| September 12, 2024 | 103.53B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.01B
Minimum
Dec 30 2020
122.01B
Maximum
Nov 07 2024
89.52B
Average
87.86B
Median
Jul 28 2021
Market Cap Benchmarks
| Eli Lilly and Co | 711.90B |
| Merck & Co Inc | 252.58B |
| Pfizer Inc | 142.44B |
| Vertex Pharmaceuticals Inc | 115.99B |
| Amgen Inc | 155.82B |
Market Cap Related Metrics
| PE Ratio | 997.78 |
| PS Ratio | 3.972 |
| Price to Book Value | 6.058 |
| Price to Free Cash Flow | 11.92 |
| Price | 89.80 |
| Earnings Yield | 0.10% |
| Operating PE Ratio | 14.71 |
| Normalized PE Ratio | 20.04 |